Publications by authors named "Mark Jeng"

Claim this Profile
A
Aging-related, senescence-associated secretory phenotype and allogeneic hematopoietic cell transplantation outcomes in older patients.
Mark Y Jeng, Phillip Wong, Jessica R Flynn, Erika Ritter, Caleb Ho

J Geriatr Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Significance of MTAP Deletions and their Overlap with Concurrent Oncogenic Driver Alterations Including EGFR in Non-Small Cell Lung Cancer.
Jessica S Ross, Rohit Thummalapalli, Christopher A Febres-Aldana, Daniel Muldoon, Christina Falcon, Mark Y Jeng

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 Study of Amivantamab Plus Lazertinib in Previously Treated Patients With EGFR-Mutant Lung Cancers With Brain and Leptomeningeal Metastases.
Monica F Chen, Jake June-Koo Lee, Noura J Choudhury, Angela B Hui, Mark Y Jeng

J Thorac Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas.
Jessica S Ross, Rohit Thummalapalli, Kristine Lacuna, Rania G Aly, Marina K Baine, Mark Y Jeng

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer.
Federica Pecci, Rohit Thummalapalli, Stephanie L Alden, Biagio Ricciuti, Joao V Alessi, Mark Jeng

Clin Cancer Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes After Radiation for Oligoprogressive Disease Sites in Patients With -Mutant Lung Cancer Treated With Osimertinib.
Monica F Chen, Mark Y Jeng, Jennifer Ma, Prashasti Agrawal, Elizabeth Dunne

JCO Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Longitudinal Biomarkers Guide Treatment Decisions? Time Will Tell.
Mark Y Jeng, Adam J Schoenfeld

Clin Cancer Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal Metastasis in the Era of CNS-Penetrant Tyrosine Kinase Inhibitor Therapy.
Mark Y Jeng, Helena A Yu

J Clin Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of disease control remains a major barrier to transplant for older patients with AML.
Mark Y Jeng, Denice Kong, Raja Rajalingam, Richard J Lin, Rebecca L Olin

Bone Marrow Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved outcomes of octogenarians and nonagenarians with acute myeloid leukemia in the era of novel therapies.
Mark Y Jeng, Ritika Dutta, Irena T Tan, Tian Y Zhang, Gabriel N Mannis

Am J Hematol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin Disorders.
Mark Y Jeng, Maxwell R Mumbach, Jeffrey M Granja, Ansuman T Satpathy, Howard Y Chang

J Invest Dermatol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study.
Anne Lynn S Chang, Duy C Tran, John G D Cannon, Shufeng Li, Mark Jeng

J Am Acad Dermatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic reprogramming of human CD8 memory T cells through loss of SIRT1.
Mark Y Jeng, Philip A Hull, Mingjian Fei, Hye-Sook Kwon, Chia-Lin Tsou

J Exp Med· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SMYD2-Mediated Histone Methylation Contributes to HIV-1 Latency.
Daniela Boehm, Mark Jeng, Gregory Camus, Andrea Gramatica, Roland Schwarzer

Cell Host Microbe· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.
Mark Y Jeng, Ibraheem Ali, Melanie Ott

Crit Rev Biochem Mol Biol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis